Twitter Inc. (NYSE: TWTR) managed to debut with a wildly successful initial public (IPO) offering on Thursday. 24/7 Wall St. wanted to offer up an analyst montage of the calls that have already been made and to show which research firms will be restricted until December from making research calls.

The firms that were in the underwriting syndicate must abide by a mandated quiet period. The following firms have ratings:

Cantor Fitzgerald started coverage with a Buy rating, but the problem is that it assigned only a $32 price target.

The boutique firm Evercore Partners gave an Overweight rating to Twitter before it opened, and its price target was the most bullish at $43 for the stock.

RBC Capital Markets also started coverage with an Outperform rating, but its price target was down at $33.

Sterne Agee gave Twitter a very positive pre-IPO evaluation, but that was not based anywhere near the opening price strength.

Pivotal Research issued a downgrade alert on Thursday, based on how strong the IPO performed and on relative valuation to other companies. Its target price was $30.

Wedbush Morgan has initiated coverage with a Neutral rating.

What will be hard to consider for most investors is that Twitter is valued almost more like an emerging biotech than as a tech stock. After all, it is worth more than an unheard of 50 times sales.

One trader who received shares at the IPO price on Thursday also told 24/7 Wall St. that some hedge funds and traders are already looking for ways to borrow Twitter shares. That means short sellers want to stick their flag in the sand as well.

Twitter closed at $44.90 on Thursday’s debut after a $27 per-IPO price. Maybe reality sets in, maybe not. The firms that were in the underwriting syndicate and will be restricted until December are as follows:

• Goldman Sachs
• Morgan Stanley
• J.P. Morgan
• Bank of America Merrill Lynch
• Deutsche Bank Securities
• Allen & Company
• CODE Advisors

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.